On 29 October Cara Therapeutics Inc. (NASDAQ:CARA) announced positive results from its Human Abuse Liability (HAL) trial of an intravenous (I.V.) formulation of CR845, a first-in-class peripherally-selective kappa opioid agonist. Cara Therapeutics Inc. (NASDAQ:CARA) in last trading activity decreased -2.77% to close at $8.79. Company weekly performance is -4.46% while its quarterly performance stands at -18.61%. Cara Therapeutics Inc. (NASDAQ:CARA) is -62.19% away from its 52 week high.
On 16 October Canadian Solar Inc. (NASDAQ:CSIQ) announced that it will supply 146.4 megawatts (MW) of photovoltaic (PV) modules to two utility-scale projects in Honduras. On last trading day Canadian Solar Inc. (NASDAQ:CSIQ) decreased -2.53% to close at $29.70. Its volatility for the week is 5.69% while volatility for the month is 7.24%. CSIQ’s sales growth for past 5 years was 18.60% and its EPS growth for past 5 years was 35.80%. Canadian Solar Inc. (NASDAQ:CSIQ) monthly performance is -9.15%.
On 17 October Federal Agricultural Mortgage Corp. (NYSE:AGM) announced that it has entered into eight separate purchase agreements with separate sellers to acquire nine farms in Arkansas and Nebraska totaling approximately 6,080 acres for aggregate consideration of approximately $25 million in cash. The acquisitions are expected to close in 2014, and are subject to customary closing conditions. On last trading day Federal Agricultural Mortgage Corp. (NYSE:AGM) decreased -0.06% to close at $33.53. Its volatility for the week is 1.96% while volatility for the month is 2.42%. AGM’s sales growth for past 5 years was -1.60% and its EPS growth for past 5 years was 19.30%. Federal Agricultural Mortgage Corp. (NYSE:AGM) monthly performance is 4.07%.
Quanex Building Products Corporation (NYSE:NX) was downgraded by ING Group from an “outperform” rating to an “in-line” rating in a research note issued on Friday. They currently have a $20.00 price target on the stock, down from their previous price target of $21.00. ING Group’s price target would indicate a potential upside of 11.67% from the company’s current price. Quanex Building Products Corporation (NYSE:NX) has 0.87% insider ownership while its institutional ownership stands at 93.50%. In last trading activity company’s stock closed at $20.14.
UDR, Inc. (NYSE:UDR) released its earnings data on Tuesday. The company reported $0.41 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.40 by $0.01. The company had revenue of $206.75 million for the quarter, compared to the consensus estimate of $203.50 million. During the same quarter in the prior year, the company posted $0.36 earnings per share. The company’s quarterly revenue was up 8.2% on a year-over-year basis. UDR updated its Q4 guidance to $0.38-0.40 EPS. On Wednesday shares of UDR, Inc. (NYSE:UDR) closed at $30.50. Company’s sales growth for last 5 years was 5.20% and EPS growth for next 5 years is recorded as 6.60%.